Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia

Sleep and Breathing

Volumn 17, Issue 1, 2013, Pages 365-371

  Okur, Hacer Kuzu ^a,e   Pelin, Zerrin ^b   Yuksel, Meral ^c   Yosunkaya, Sebnem ^d  

^a Sleep Disorders Unit   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

^e Mehmet Sengün Sok ^*  (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Intermittent hypoxia; Lipid peroxidation; Obstructive sleep apnea; Oxidative stress; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; LIPID; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOXEMIA; INTERMITTENT HYPOXIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NIGHT SLEEP; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; SNORING;

ADULT; AGED; ANOXIA; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CEREBRAL CORTEX; CIRCADIAN RHYTHM; COMORBIDITY; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; POLYSOMNOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84874190327     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0703-5     Document Type: Article

References (51)

1. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M (1999) An independent association between obstructive sleep apnoea and coronary artery disease. Eur Res J 14:179-184
2. Yaggi H, Mohsenin V (2003) Sleep-disordered breathing and stroke. Clin Chest Med 24:223-237
3. Camilli AG, Robbins DR, Lebowitz MD (1991) Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 133:795-800
4. MacNee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824-833
5. Kluchova Z, Perrasova P, Joppa DZ, Tkacova R (2007) The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51-56
6. 18 F-FDG PET pilot study. J Nucl Med 51:1357-1360
7. Lavie P, Lavie L (2008) Cardiovascular morbidity and mortality in obstructive sleep apnea. Curr Pharmaceut Des 14:3466-3473
8. Fletcher EC, Miller J, Divine GW, Fletcher RN, Miller T (1987) Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tension above 60 mmHg. Chest 92:604-608
9. 2 >60 mmHg. Am Rev Respir Dis 145:1070-1076
10. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656-664
11. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711-715
12. Mackness MI, Durrington PN, Mackness B (2004) The role of paraoxonase 1 activity in cardiovascular disease. Am J Cardiovasc Drugs 4(4):211-217
13. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123-128
14. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127:1674-1679
15. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, Q'Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28:378-385
16. MacNee W (2000) Oxidants/antioxidants and COPD. Chest 117:303-317
17. Chess PR, O'Reilly MA, Sachs F, Finkelstein JN (2005) Reactive oxidant and p42/44MAP kinase signaling is necessary for mechanical strain-induced proliferation in pulmonary epithelial cells. J Appl Physiol 99(3):1226-1232
18. Papaiahgari S, Yerrapureddy A, Hassoun PM, Garcia JG, Birukov KG, Reddy SP (2007) EGFR-activated signaling and actin remodeling regulate cyclic stretch-induced NRF2-ARE activation. Am Respir Cell Mol Biol 36(3):304-312
19. McQuaid KE, Smyth EM, Keenan AK (1996) Evidence for modulation of hydrogen peroxide induced endothelial barrier dysfunction by nitric oxide in vitro. Eur J Pharmacol 307(2):233-241
20. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-63
21. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656-664
22. Friedman GD, Klatsky AL (1976) Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 294:1071-1075
23. Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15(4):376-381
24. Pauwels RA, BuIst AS, Calverley PMA (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256-1276
25. Iber K, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, Westchester
26. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193-199
27. Yagi K (1984) Assay for blood plasma or serum. Methods Enzymol 105:328-31
28. Halliwell B, Chirico S (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57:715-725
29. Alzoghaibi MA, BaHammam AS (2011) The effect of night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath;doi 10.1007/s11325-011-0531-z.
30. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients whit severe obstructive sleep apnea and metabolic syndrome. Chest 134:686-692
31. Vatansever E, Surmen-Gur E, Ursavaş A, Karadaǧ M (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15:275-282
32. Rahman I, Skwarska E, MacNee W (1997) Attenuation of oxidant/antioxidant imbalance during treatment of exacerbation of chronic obstructive pulmonary disease. Thorax 52:565-568
33. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, Spasic S, Vujic T, Stefanovic A, Ilic A, Ivanisevic J (2011) Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med 105:31-37
34. Aviram M (1996) Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidant. Eur J Clin Chem Clin Biochem 34:599-608
35. Steinberg DS, Parthasarathy TE, Carew JC Khoo, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
36. Aviram M (1993) Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98:1-9
37. Mitchinson MJ, Ball RY, Carpenter KL, Enright JH (1990) Macrophages and ceroid in human atherosclerosis. Eur Heart J 11:116-121
38. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. J Clin Invest 101(8):1581-1590
39. Leuenberger UA, Hogeman CS, Quraishi S, Linton-Frazier L, Gray KS (2007) Short-term intermittent hypoxia enhances sympathetic responses to continuous hypoxia in humans. J Appl Physiol 103:835-842
40. Gilmartin GS, Lynch M, Tamisier R, Weiss JW (2010) Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 299:925-931
41. Tamisier R, Gilmartin GS, Launois SH, Pepin JL, Nespoulet H, Thomas R, Levy P, Weiss JW (2009) A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol 107:17-24
42. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923
43. Inoue N, Kawashima S, Hirata KI, Rikitake Y, Takeshita S, Yamochi W, Akita H, Yokoyama M (1998) Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production. Am J Physiol 274:1928-1932
44. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673-4676
45. Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, Kojima M, Wakai K, Toyoshima H, Tamakoshi K, Watanabe Y, Hayakawa N, Maruta M, Watanabe M, Kato K, Ohta Y, Tamakoshi A (2003) JACC Study Group. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev 4:259-266
46. Harman SM, Liang L, Tsitouras PD, Gucciardo F, Heward CB, Reaven PD, Ping W, Ahmed A, Cutler RG (2003) Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2) measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 35:1301-1309
47. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R (2003) Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 35:697-710
48. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551
49. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28
50. Kashiwagi A, Shinozaki K, Nishio Y, Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hikada H, Yasuda H, Kikkawa R (1999) Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 277:976-983
51. Tekes S, Isik B, Yildiz T, Simsek S, Isik MR, Budak T (2010) Chronic obstructive pulmonary disease and paraoxonase 1 192 and 55 gene polymorphisms. Biotechnology & Biotechnological Equipment 24(1):1644-1647